14 participants
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2026-02-04
- Completion:
- 2027-03-31
Conditions
- TP53 Y220C Mutation
- Advanced Solid Tumors
Interventions
- DRUG
No Results Yet